Zanubrutinib-rituximab(ZR) in Patients With Newly Diagnosed Untreated Mantle Cell Lymphoma
Condition:   Untreated Mantle Cell Lymphoma Interventions:   Drug: zanubrutinib and rituximab;   Drug: BEAM pretreatment;   Drug: zanubrutinib maintenance Sponsor:   The First Affiliated Hospital of Soochow University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 17, 2022 Category: Research Source Type: clinical trials